Epinomics

San Francisco, United States Founded: 2013 • Age: 13 yrs Acquired By 10X Genomics
Epigenomics research and development services for DNA sequencing are provided.

About Epinomics

Epinomics is a Healthcare company based in San Francisco (United States) founded in 2013, and was acquired by 10X Genomics in August 2018. Epigenomics research and development services for DNA sequencing are provided. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Helix, Benchling and Genuity Science; 3 of its 3 listed competitors have raised funding.

Company details

Epinomics was founded in 2013 and is based in San Francisco, United States. Operations focus on the epigenomics sector, where research and development services for DNA sequencing are offered to biotech and pharmaceutical companies. A bioinformatics tool is developed to facilitate personalized medicine via scientific research, data analytics, and clinical applications. Assistance is provided in identifying clinical biomarkers and progressing therapeutics development.

  • Headquarters San Francisco, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website epinomics.co
  • Social X Facebook
  • Acquired by 10X Genomics (Aug 2018)
Key Metrics

Investors in Epinomics

Epinomics has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.

All
InvestorDescriptionFounded YearDomainLocation
Instrument systems for genomic research and sequencing libraries are developed.
201210xgenomics.comPleasanton, United States
Premium access

Investor details for Epinomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Epinomics

2 dated milestones of Epinomics across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Epinomics is founded.
  2. Exit Acquired by 10X Genomics.

Competitors of Epinomics

Epinomics has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and Genuity Science.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
helix.com2015San Francisco, United States$435M
Genomic database for clinical research is provided.
benchling.com2012San Francisco, United States$411.9M640
Cloud-based bioinformatics platform is offered for biotech research.
genuitysci.com2013Boston, United States$515M
AI-based omics data analysis solutions are provided to researchers.
Premium access

Detailed competitors of Epinomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Epinomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Epinomics

10x Genomics Acquires Epinomics
Prnewswire β€’ 8 years ago
Premium access

Complete news archive for Epinomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Epinomics

Epinomics was founded in 2013.

Epinomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Epinomics was founded in 2013 and is based in San Francisco, United States. Operations focus on the epigenomics sector, where research and development services for DNA sequencing are offered to biotech and pharmaceutical companies. A bioinformatics tool is developed to facilitate personalized medicine via scientific research, data analytics, and clinical applications. Assistance is provided in identifying clinical biomarkers and progressing therapeutics development.

Epinomics's top competitors include Helix, Benchling and Genuity Science.

Epinomics has 1 investor. Key investors include 10X Genomics.

Yes. Epinomics was acquired by 10X Genomics in August 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available